


Healthcare News Roundup: Venture Capital
HSMN NewsFeed - 9 Feb 2016
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
HSMN NewsFeed - 4 Feb 2016
GTCR Announces Third Partnership with Ed Fiorentino to Form TerSera(TM) Therapeutics
GTCR Announces Third Partnership with Ed Fiorentino to Form TerSera(TM) Therapeutics
HSMN NewsFeed - 21 Jan 2016
vasopharm Announces EUR 20 Million Fundraising to Progress Treatment for Traumatic Brain Injury
vasopharm Announces EUR 20 Million Fundraising to Progress Treatment for Traumatic Brain Injury
HSMN NewsFeed - 19 Jan 2016
ZipLine(R) Medical Secures $19 Million Financing Led by New Investor, MVM Life Science Partners LLP
ZipLine(R) Medical Secures $19 Million Financing Led by New Investor, MVM Life Science Partners LLP
HSMN NewsFeed - 19 Jan 2016
Twist Bioscience Completes $61 Million Series D Financing And $20 Million Debt Facility
Twist Bioscience Completes $61 Million Series D Financing And $20 Million Debt Facility
HSMN NewsFeed - 13 Jan 2016
EnteroMedics Announces Closing of $11 Million Tranche from Previously-Announced Convertible Notes Offering
EnteroMedics Announces Closing of $11 Million Tranche from Previously-Announced Convertible Notes Offering
HSMN NewsFeed - 11 Jan 2016
Iconic Therapeutics Closes Series C Financing With New and Existing Investors
Iconic Therapeutics Closes Series C Financing With New and Existing Investors
HSMN NewsFeed - 6 Jan 2016
NextCure, Inc., New Immuno-Oncology Firm, Announces $67 Million Series A Financing
NextCure, Inc., New Immuno-Oncology Firm, Announces $67 Million Series A Financing
